A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2007
10/24/2007	EP1121431B9 Non-endogenous, constitutively activated human g protein-coupled receptors
10/24/2007	EP0723588B1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
10/24/2007	CN101061097A Novel gamma secretase inhibitors
10/24/2007	CN101060840A Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and ATP levels in cells
10/24/2007	CN101058832A Method for detecting growth hormone variations in humans, the variations and their uses
10/24/2007	CN101058579A Camptothecin analogs and methods of preparation thereof
10/24/2007	CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy
10/24/2007	CN101057909A Composition with multiple health care functions and its preparation method
10/24/2007	CN101057856A Fast recovery agent for seeding vitality used in aquiculture
10/24/2007	CN101057853A Antiadhesive carbohydrates
10/24/2007	CN101057678A Composition containing natural plant extraction or monomer
10/24/2007	CN101057668A Functional health care beverage and preparation method
10/24/2007	CN101057635A Low-salinity autumn and winter cultivation ecological bait for litopenaeus vannamei and its preparation method
10/24/2007	CN100344638C Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators
10/24/2007	CN100344632C 稠合的呋喃化合物 Fused furan compound
10/24/2007	CN100344362C Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof
10/24/2007	CN100344312C Prepn process of granule for treating children's hyperkinesia and its quality control method
10/24/2007	CN100344295C Ganoderma lucidum capsule of lycopene
10/24/2007	CN100344234C Pesticidal formulation
10/23/2007	US7285683 Bicyclic and tricyclic cannabinoids
10/23/2007	US7285680 β-alanine derivatives and the use thereof
10/23/2007	US7285666 Pyrazolo[1,5-a] pyridines and medicines containing the same
10/23/2007	US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007	US7285662 Therapeutic heterocyclic compounds
10/23/2007	US7285654 Stimulus-inducible protein kinase complex and methods of use therefor
10/23/2007	US7285574 Methods for treating neural cell swelling
10/23/2007	US7285572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
10/23/2007	US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007	US7285552 For prevention and/or treatment for HIV infection or AIDS induced by the infection
10/23/2007	US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007	US7285547 E.g., N'-hydroxy-3-((1-((2-methyl-1-piperidinyl)carbonyl)-2-(2 -naphthylsulfonyl)hydrazino)methyl)benzenecarboximidamide
10/23/2007	US7285539 Using fusion proteins comprising HCV NS3, NS4, NS5a, and NS5b polypeptides and polynucleotides encoding them
10/23/2007	US7285538 Gene therapy; mutant Dna
10/23/2007	US7285535 Administering TIRAP to block Toll/Interleukin-1 Receptor Adaptor Protein signaling in a cell; for treatment of inflammation and inducing or affecting immune response.
10/23/2007	US7285525 Suppression of immune response via inhibition of cathepsin S
10/23/2007	US7285293 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein
10/23/2007	US7285279 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/23/2007	CA2478971C Androstenones
10/23/2007	CA2449679C Androstenones
10/23/2007	CA2391098C Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/23/2007	CA2384433C Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
10/23/2007	CA2334910C New use of a pyridazinone derivative
10/23/2007	CA2295088C Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates
10/23/2007	CA2244209C Improved concentrated injection and infusion solutions for intravenous administration
10/18/2007	WO2007117472A2 Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells
10/18/2007	WO2007117398A2 Non-peptidic molecules for detecting and treating tumors
10/18/2007	WO2007117038A1 Prophylactic/therapeutic agent for cancer
10/18/2007	WO2007116945A1 Marker for predicting graft-versus-host disease and utilization of the same
10/18/2007	WO2007116925A1 hCL-K1 POLYPEPTIDE HAVING COLLECTIN ACTIVITY
10/18/2007	WO2007116901A1 Novel arylamide derivative
10/18/2007	WO2007116866A1 Hetero compound
10/18/2007	WO2007116731A1 Composition containing reduced coenzyme a
10/18/2007	WO2007115473A1 Pyrrole derivatives inhibitors, their curative uses
10/18/2007	WO2007092829A3 Stabilized compositions of proteins having a free thiol moiety
10/18/2007	WO2003061560A3 Replication competent dual-ad vectors for vaccine and immunotherapy applications
10/18/2007	US20070244158 Piperdine Compound and Process for Preparing the Same
10/18/2007	US20070244147 Therapeutic agent for schizophrenia
10/18/2007	US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007	US20070244134 Selective antagonists of A2A adenosine receptors
10/18/2007	US20070244132 Fused Heterocyclic Compound
10/18/2007	US20070244127 Stable Dosage Form of Phenylalanine Derivatives
10/18/2007	US20070244063 Inducing angiogenesis comprising contacting endothelial cells expressing Bv8 receptor with a polypeptide comprising the amino acid sequence of SEQ ID NO:2; using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival; screening for Bv8 modulators
10/18/2007	US20070244030 Method for Assessing Cancerous State
10/18/2007	US20070243226 Growth factor complex
10/18/2007	US20070243215 Adjuvant for Dna Vaccines
10/18/2007	US20070243214 Genes and proteins associated with angiogenesis and uses thereof
10/18/2007	US20070243183 Use of factor VIIa or factor VIIa equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage
10/18/2007	US20070243164 Treating Skin Cancer
10/18/2007	US20070243163 Respiratory tract delivery of interferon-tau
10/18/2007	US20070243144 External Preparation
10/18/2007	US20070243135 Method of treating fetal growth retardation and placental ischaemia and insufficiency
10/18/2007	CA2648629A1 Marker for predicting graft-versus-host disease and utilization of the same
10/18/2007	CA2648303A1 5-[monocyclic(hetero)arylsubstituted-1,2,4-oxadliazol-3-yl]-(fused heteroaryl substituted) compounds and their use as s1p1 agonists
10/18/2007	CA2647502A1 Onco-tool compositions and methods of use for detecting and treating tumors
10/17/2007	EP1845163A2 Adeno-associated virus serotype l nucleic acid sequences, vetors and host cells containing same
10/17/2007	EP1845106A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
10/17/2007	EP1845091A1 Process for producing muscarine receptor antagonist and intermediate therefor
10/17/2007	EP1845090A1 Amide compound and thrombopoietin receptor activator
10/17/2007	EP1844781A1 Use of sodium channel blockers for the treatment of preterm labor
10/17/2007	EP1844771A2 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
10/17/2007	EP1844767A2 Epoxide hydrolase complexes and methods therewith
10/17/2007	EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/17/2007	EP1843789A2 Compositions and methods for treating fibrotic disorders
10/17/2007	EP1843772A1 Intravenous formulations of pde-5 inhibitors
10/17/2007	EP1531684B1 Method for controlling hairballs
10/17/2007	EP1492540B1 The use of devazepide as analgesic agent
10/17/2007	EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007	EP1416916B1 Chitin microparticles and their medical uses
10/17/2007	EP1412028B1 Tetrahydroindolone derivatives linked to arylpiperazines
10/17/2007	EP1392713B1 Liver x receptor agonists
10/17/2007	EP1372638A4 Functional role for cannabinoids in autonomic stability during sleep
10/17/2007	EP1341769B1 Bacterial gyrase inhibitors and uses thereof
10/17/2007	EP1313717B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
10/17/2007	EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007	EP1267848B1 Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer
10/17/2007	EP1225882B1 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
10/17/2007	EP1173432B1 Piperidine-indole compounds having 5-ht6 affinity
10/17/2007	EP1153034B1 Growth hormone secretagogues
10/17/2007	EP1093818B9 Powdery preparation for mucosal administration containing polymeric medicine
10/17/2007	EP1092018B1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT

1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 1564